Biofrontera (BFRI) Selling, General & Administrative (2020 - 2026)
Biofrontera (BFRI) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Biofrontera | 18.35 Mn | 13.64 Mn | 9.59 Mn | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Dec 31, 2025 | 21.19 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Mar 31, 2025 | 8.65 Mn |
| Dec 31, 2024 | 8.20 Mn |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 18.30 Mn |
| Sep 30, 2023 | 8.62 Mn |
| Jun 30, 2023 | 11.46 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 10.09 Mn |
| Sep 30, 2022 | 7.77 Mn |
| Jun 30, 2022 | 9.67 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 9.10 Mn |
| Sep 30, 2021 | 17.09 Mn |
| Jun 30, 2021 | 5.55 Mn |